Treatment of confirmed B12 deficiency in hemodialysis patients improves Epogen® requirements

BACKGROUND: Vitamin B12 deficiency may have deleterious effects on end stage renal disease (ESRD) patients on maintenance hemodialysis, and may increase erythropoietin stimulating agent (ESA) resistance, yet little is known about its prevalence in this population. METHODS: Serum vitamin B12 and meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Saifan, Chadi, Samarneh, Mark, Shtaynberg, Norbert, Nasr, Rabih, El-Charabaty, Elie, El-Sayegh, Suzanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681404/
https://www.ncbi.nlm.nih.gov/pubmed/23776388
http://dx.doi.org/10.2147/IJNRD.S44660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681404/
https://www.ncbi.nlm.nih.gov/pubmed/23776388
http://dx.doi.org/10.2147/IJNRD.S44660

Ejemplares similares